NKTR News

NKTR Investors Have Opportunity to Lead Nektar Therapeutics Securities Fraud Lawsuit with the Schall Law Firm

Nektar Therapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NKTR USA - English USA - English

ROSEN, A LEADING AND RANKED FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Pomerantz LLP Moves Forward with Class Action Litigation Against Nektar Therapeutics – NKTR

ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - NKTR

Pomerantz LLP Pursues Class Action Against Nektar Therapeutics – NKTR

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Pomerantz LLP Moves Forward with Class Action Lawsuit Against Nektar Therapeutics – NKTR

Pomerantz LLP Moves to File Class Action Litigation Against Nektar Therapeutics – NKTR

LU INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Lufax (LU) Investors of Securities Class Action Deadline on May 20, 2026 Ready to Announce with Confidence?